G Protein-Coupled Receptors of the Hypothalamic-Pituitary-Gonadal Axis: A Case for GnRH, LH, FSH, and GPR54 Receptor Ligands

被引:39
|
作者
Heitman, Laura H. [1 ]
Ijzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Div Med Chem, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
non-peptidic; ligands; structure-affinity relationships; GPCRs; HPG-axis;
D O I
10.1002/med.20129
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The hypothalamic-pituitary-gonadal (HPG) axis, important in reproduction and sex hormone-dependent diseases, is regulated by a number of G protein-coupled receptors. The recently "deorphanized" GPR54 receptor activated by the peptide metastin is thought to be the key regulator of the axis, mainly by releasing gonadotropin-releasing hormone (GnRH) from the hypothalamus. The latter decapeptide, through the activation of the GnRH receptor in the anterior pituitary, causes the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which subsequently activate their respective receptors on the gonadotrope cells. In this review we will discuss the small molecule agonists and antagonists that are currently being developed to intervene with the action of these four receptors. For GnRH receptors, 14 different chemical classes of non-peptidic antagonists have been reported, while for the LH receptor three classes of agonists have been described. Both agonists and antagonists have been introduced for the FSH receptor. Recently, the first non-peptidic agonist for GPR54 was reported. (C) 2008 Wiley Periodicals, Inc. Mad Res Rev, 28, No. 6, 975-1011, 2008
引用
收藏
页码:975 / 1011
页数:37
相关论文
共 50 条
  • [1] Restoring function to inactivating G protein-coupled receptor variants in the hypothalamic-pituitary-gonadal axis
    Radomsky, Tarryn
    Anderson, Ross C.
    Millar, Robert P.
    Newton, Claire L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (09)
  • [2] Folding, misfolding, and regulation of intracellular traffic of G protein-coupled receptors involved in the hypothalamic-pituitary-gonadal axis
    Ulloa-Aguirre, Alfredo
    Anderson, Ross C.
    Zarinan, Teresa
    Gutierrez-Sagal, Ruben
    Jardon-Valadez, Eduardo
    Newton, Claire L.
    ANDROLOGY, 2025,
  • [3] Bench and bedside - The G protein-coupled receptor GPR54 and puberty
    Beier, DR
    Dluhy, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17): : 1589 - 1592
  • [4] Metastin and its g protein-coupled receptor, GPR54: Critical pathway modulating GnRH secretion
    Seminara, SB
    FRONTIERS IN NEUROENDOCRINOLOGY, 2005, 26 (3-4) : 131 - 138
  • [5] EFFECTS OF LH-FSH-RELEASING HORMONE IN PATIENTS WITH DISEASE OF HYPOTHALAMIC-PITUITARY-GONADAL AXIS
    BESSER, GM
    MARSHALL, JC
    MCNEILLY, A
    MORTIMER, C
    TONBRIDG.M
    ACTA ENDOCRINOLOGICA, 1973, : 258 - 258
  • [6] The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54
    Kotani, M
    Detheux, M
    Vandenbbogaerde, A
    Communi, D
    Vanderwinden, JM
    Le Poul, E
    Brézillon, S
    Tyldesley, R
    Suarez-Huerta, N
    Vandeput, F
    Blanpain, C
    Schiffmann, SN
    Vassart, G
    Parmentier, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) : 34631 - 34636
  • [7] Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54
    Pallais, J. Carl
    Bo-Abbas, Yousef
    Pitteloud, Nelly
    Crowley, William F., Jr.
    Seminara, Stephanie B.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 254 : 70 - 77
  • [8] Kisspeptin activation of GPR54, a G-protein coupled receptor required for puberty and reproduction, directly stimulates GNRH secretion in GNRH neuronal cells.
    Kuohung, W
    Mukhtyar, D
    Posner, SF
    Ojeda, SR
    Seminara, SB
    Crowley, WF
    Kaiser, UB
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 296A - 296A
  • [9] The GnRH analogues affect novel neuropeptide SMIM20/phoenixin and GPR173 receptor expressions in the female rat hypothalamic-pituitary-gonadal (HPG) axis
    Suszka-Switek, Aleksandra
    Palasz, Artur
    Filipczyk, Lukasz
    Menezes, Itiana Castro
    Mordecka-Chamera, Kinga
    Angelone, Tommaso
    Bogus, Katarzyna
    Bacopoulou, Flora
    Worthington, John J.
    Wiaderkiewicz, Ryszard
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (04) : 350 - 359
  • [10] Androxal™ (enclomiphene citrate) acts centrally on the hypothalamic-pituitary-gonadal axis to increase lh, fsh and testosterone in men with adult idiopathic hypogonadotrophic hypogonadism
    Wiehle, Ronald D.
    van As, Andre
    Podolski, Joseph S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 426 - 426